IN167198B - - Google Patents

Info

Publication number
IN167198B
IN167198B IN235/MAS/88A IN235MA1988A IN167198B IN 167198 B IN167198 B IN 167198B IN 235MA1988 A IN235MA1988 A IN 235MA1988A IN 167198 B IN167198 B IN 167198B
Authority
IN
India
Application number
IN235/MAS/88A
Other languages
English (en)
Inventor
L Goldstein Allan
Sung Wang Su
Original Assignee
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viral Technologies Inc filed Critical Viral Technologies Inc
Publication of IN167198B publication Critical patent/IN167198B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN235/MAS/88A 1986-05-19 1988-04-12 IN167198B (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86459986A 1986-05-19 1986-05-19

Publications (1)

Publication Number Publication Date
IN167198B true IN167198B (ko) 1990-09-15

Family

ID=25343634

Family Applications (1)

Application Number Title Priority Date Filing Date
IN235/MAS/88A IN167198B (ko) 1986-05-19 1988-04-12

Country Status (17)

Country Link
EP (1) EP0246829B1 (ko)
JP (3) JPH089636B2 (ko)
KR (1) KR910002690B1 (ko)
CN (1) CN87103568A (ko)
AT (1) ATE100469T1 (ko)
AU (1) AU606595B2 (ko)
DE (1) DE3788822T2 (ko)
DK (1) DK173040B1 (ko)
ES (1) ES2061495T3 (ko)
GB (1) GB2190679B (ko)
IE (1) IE60274B1 (ko)
IL (1) IL82471A (ko)
IN (1) IN167198B (ko)
MX (1) MX167236B (ko)
NZ (1) NZ220200A (ko)
PH (1) PH26239A (ko)
ZA (1) ZA873215B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
ATE105413T1 (de) * 1989-02-01 1994-05-15 Du Pont Hiv p17-test fuer die ueberwachung des verlaufs von aids.
WO1990013573A1 (en) * 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
DE4106686A1 (de) * 1991-03-02 1992-09-03 Daimler Benz Ag Verriegelungsanordnung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6093400A (en) * 1996-08-09 2000-07-25 Cel Sci Corporation Modified HGP-30 peptides, conjugates, compositions and methods of use
EP0969864A1 (en) 1996-08-09 2000-01-12 Viral Technologies, Inc. Hiv p-17 peptide fragment, compositions containing and methods for producing and using same
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
DE60045249D1 (de) 2000-12-21 2010-12-30 Semiconductor Components Ind Verfahren und Vorrichtung zur Reduktion von Schaltgeräuschen in einem Transformator eines Schaltnetzteils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
US4517119A (en) * 1983-04-04 1985-05-14 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4504415A (en) * 1983-04-04 1985-03-12 Hoffman-La Roche Inc. Synthesis of thymosin α1 and desacetyl thymosin α1

Also Published As

Publication number Publication date
ATE100469T1 (de) 1994-02-15
EP0246829A3 (en) 1989-08-09
AU606595B2 (en) 1991-02-14
GB8711567D0 (en) 1987-06-17
IL82471A (en) 1993-02-21
ZA873215B (en) 1987-10-28
DK173040B1 (da) 1999-11-29
JPH0925300A (ja) 1997-01-28
KR910002690B1 (ko) 1991-05-03
EP0246829B1 (en) 1994-01-19
JPS6327498A (ja) 1988-02-05
JPH089636B2 (ja) 1996-01-31
DE3788822T2 (de) 1994-07-28
DK245287A (da) 1987-11-20
MX167236B (es) 1993-03-11
KR870011154A (ko) 1987-12-21
PH26239A (en) 1992-04-01
IE60274B1 (en) 1994-06-29
ES2061495T3 (es) 1994-12-16
GB2190679A (en) 1987-11-25
GB2190679B (en) 1991-02-20
IE871289L (en) 1987-11-19
IL82471A0 (en) 1987-11-30
JP2598245B2 (ja) 1997-04-09
NZ220200A (en) 1990-08-28
EP0246829A2 (en) 1987-11-25
DE3788822D1 (de) 1994-03-03
DK245287D0 (da) 1987-05-14
AU7313587A (en) 1987-11-26
CN87103568A (zh) 1988-01-27
JPH083200A (ja) 1996-01-09

Similar Documents

Publication Publication Date Title
DE3790492T1 (ko)
IN169309B (ko)
IN168193B (ko)
DE3790601T1 (ko)
IN167198B (ko)
DE3790192T (ko)
AU7354491A (ko)
IN170512B (ko)
IN169202B (ko)
DE3790582T1 (ko)
AU6562586A (ko)
AU7131791A (ko)
IN169605B (ko)
RU1461319C (ko)
AU5783386A (ko)
DE3690779T1 (ko)
IN165454B (ko)
IN163113B (ko)
AU5878886A (ko)
AU5644686A (ko)
IN168088B (ko)
AU6011386A (ko)
IN167599B (ko)
AU5767086A (ko)
AU5857886A (ko)